Profile picture

Doctor Sergi Yun Viladomat

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)
Follow
Logo ESC

Contributor content

International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction
Presentation
International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction
Read more
HERMeS Trial: mHealth solutions in heart failure monitoring
Presentation
HERMeS Trial: mHealth solutions in heart failure monitoring
Read more
Effect of telemedicine on health-related quality of life in patients with heart failure: insights from the iCOR randomised controlled trial
Presentation
Effect of telemedicine on health-related quality of life in patients with heart failure: insights from the iCOR randomised controlled trial
Read more
Effect of telemedicine on self-care in heart failure patients: insights from the iCOR randomised controlled trial
Presentation
Effect of telemedicine on self-care in heart failure patients: insights from the iCOR randomised controlled trial
Read more
Usefulness of telemedicine-based heart failure monitoring according to "eHealth literacy" domains: insights from the iCOR randomised controlled trial.
Presentation
Usefulness of telemedicine-based heart failure monitoring according to "eHealth literacy" domains: insights from the iCOR randomised controlled trial.
Read more
Effectiveness of telemedicine in patients with heart failure according to frailty phenotypes: insights from the iCOR randomised controlled trial
Presentation
Effectiveness of telemedicine in patients with heart failure according to frailty phenotypes: insights from the iCOR randomised controlled trial
Read more
Frailty phenotypes in patients with heart failure in the early post-discharge period: insights from the iCOR randomised controlled trial and a machine learning-based clustering analysis
Presentation
Frailty phenotypes in patients with heart failure in the early post-discharge period: insights from the iCOR randomised controlled trial and a machine learning-based clustering analysis
Read more

ESC 365 is supported by

novartis Explore sponsored resources